Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-25-107391
Filing Date
2025-11-06
Accepted
2025-11-06 07:35:45
Documents
104
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q coll-20250930x10q.htm   iXBRL 10-Q 2748438
2 EX-31.1 coll-20250930xex31d1.htm EX-31.1 12975
3 EX-31.2 coll-20250930xex31d2.htm EX-31.2 13002
4 EX-32.1 coll-20250930xex32d1.htm EX-32.1 7558
5 EX-32.2 coll-20250930xex32d2.htm EX-32.2 7399
6 GRAPHIC coll-20250930x10q001.jpg GRAPHIC 9164
  Complete submission text file 0001104659-25-107391.txt   13643802

Data Files

Seq Description Document Type Size
7 EX-101.SCH coll-20250930.xsd EX-101.SCH 86130
8 EX-101.CAL coll-20250930_cal.xml EX-101.CAL 117483
9 EX-101.DEF coll-20250930_def.xml EX-101.DEF 330173
10 EX-101.LAB coll-20250930_lab.xml EX-101.LAB 665346
11 EX-101.PRE coll-20250930_pre.xml EX-101.PRE 523947
107 EXTRACTED XBRL INSTANCE DOCUMENT coll-20250930x10q_htm.xml XML 3089739
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37372 | Film No.: 251456188
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)